/QLIFE.ST
QLIFE.ST Stock - Qlife Holding AB (publ)
Healthcare|Medical - DevicesSTO
$2.40+14.83%
+$0.31 (+14.83%) • Dec 23
65
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.46
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.97
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $2.64
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for QLIFE.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$2.38 – $2.42
TARGET (TP)$2.76
STOP LOSS$2.21
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.58
52W High$5.74
52W Low$1.21
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $50,000 | $244,000 | $17.99M | $39.61M | $20.75M |
| Gross Profit | $-158,000 | $-6,312,000 | $-10,749,000 | $44.54M | $35.68M |
| Gross Margin | -316.0% | -2586.9% | -59.7% | 112.4% | 172.0% |
| Operating Income | $-12,928,000 | $-168,697,000 | $-95,736,000 | $-43,866,000 | $-31,324,000 |
| Net Income | $-55,981,000 | $-159,956,000 | $-93,141,000 | $-38,797,000 | $-20,200,000 |
| Net Margin | -111962.0% | -65555.7% | -517.7% | -97.9% | -97.3% |
| EPS | $-0.34 | $-0.26 | $-0.87 | $-0.48 | $-0.26 |
Company Overview
Qlife Holding AB (publ), a med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents. The company offers Egoo.Health Platform, an integrated platform with a measuring instrument with disposable capsules and software, where each capsule contains a test for a specific biomarker or virus. Its biomarkers include C-reactive protein home-testing capsule, PHE/Phenylalanine for PKU patients, and Sars-CoV-2/Influenza multiplex for virus/bacteria tests. The company was incorporated in 2019 and is based in Helsingborg, Sweden.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
QLIFE.STBeat Rate
100%
Last 1 quarters
Avg Surprise
+99.9%
EPS vs Estimate
Beats / Misses
1/0
Last 12 quarters
Latest EPS
$-0.73
Q3 2025
EPS Surprise History
Q4 23
No data
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q3 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Sep 30, 2025 | — | $-0.73 | — | — |
Q2 2025 | May 20, 2025 | — | $-0.73 | — | — |
Q1 2025 | Feb 6, 2025 | — | $-0.00 | — | — |
Q4 2024 | Nov 7, 2024 | — | $-0.01 | — | — |
Q3 2024 | Aug 29, 2024 | — | $-0.00 | — | — |
Q2 2024 | May 28, 2024 | — | $-0.00 | — | — |
Q1 2024 | Feb 9, 2024 | — | $-0.09 | — | — |
Q4 2023 | Nov 13, 2023 | — | $-0.01 | — | — |
Q3 2023 | Aug 17, 2023 | — | $-0.02 | — | — |
Q2 2023 | May 26, 2023 | — | $-0.72 | — | — |
Q1 2023 | Feb 16, 2023 | $-285.98 | $-0.22 | +99.9% | ✓ BEAT |
Q4 2022 | Nov 25, 2022 | — | $-0.79 | — | — |
Q3 2022 | Aug 24, 2022 | — | $-0.18 | — | — |
Q2 2022 | May 5, 2022 | — | $-0.15 | — | — |
Q1 2022 | Feb 17, 2022 | — | $-0.17 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.11 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.11 | — | — |
Q2 2021 | May 5, 2021 | — | $-0.06 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.07 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.03 | — | — |
Latest News
Loading news...
Frequently Asked Questions about QLIFE.ST
What is QLIFE.ST's current stock price?
Qlife Holding AB (publ) (QLIFE.ST) is currently trading at $2.40 per share. The stock has moved +14.83% today.
What is the analyst price target for QLIFE.ST?
No analyst price targets are currently available for this stock.
What sector is Qlife Holding AB (publ) in?
Qlife Holding AB (publ) operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the STO exchange.
What is QLIFE.ST's market cap?
Qlife Holding AB (publ) has a market capitalization of $0.03 billion, making it a small-cap company.
Does QLIFE.ST pay dividends?
No, Qlife Holding AB (publ) does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare Sector2CUREX.ST
2cureX AB (publ)
$0.75
Mkt Cap: $0.0B
AINO.ST
Aino Health AB (publ)
$0.18
Mkt Cap: $0.0B
CMH.ST
Chordate Medical Holding AB (publ)
$0.61
Mkt Cap: $0.0B
EPIS-B.ST
Episurf Medical AB (publ)
$0.03
Mkt Cap: $0.0B
FLUI.ST
Fluicell AB (publ)
$11.30
Mkt Cap: $0.0B
GUARD.ST
Guard Therapeutics International AB (publ)
$1.40
Mkt Cap: $0.0B
ODI.ST
ODI Pharma AB
$3.22
Mkt Cap: $0.1B
PROGEN.ST
Prostatype Genomics AB (publ)
$0.35
Mkt Cap: $0.0B
SPERM.ST
Spermosens AB
$0.01
Mkt Cap: $0.0B
STABL.ST
Stayble Therapeutics AB (publ)
$0.21
Mkt Cap: $0.0B
Explore stocks similar to QLIFE.ST for comparison